Skip to content

A Multimodal Quantitative Evaluation of the Therapeutic Effects of Acupuncture on Motor Dysfunction in Parkinsons Disease

A Multimodal Quantitative Evaluation of the Therapeutic Effects of Acupuncture on Motor Dysfunction in Parkinsons Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001699
Enrollment
Unknown
Registered
2025-09-09
Start date
2025-09-12
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Healthy Control Group:none
Sham Acupuncture Group:Sham acupuncture combined with medication therapy, three sessions per week for four weeks
Acupuncture Group:Acupuncture combined with medication therapy, three sessions per week for four weeks

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Parkinson's Disease Group:1.Patients with idiopathic Parkinsons disease meeting the diagnostic criteria for Parkinsons disease;2.Aged between 30 and 80 years;3.Hoehn and Yahr stage 1 to 3 (modified criteria);4.Normal vision hearing and language function;5.On a stable medication regimen for at least 30 days;6.Willing to receive acupuncture treatment;7.Approved by the institutional ethics committee and signed the informed consent form. Healthy Control Group:1.Healthy individuals with confirmed exclusion of Parkinsons disease or Parkinsonian syndromes through clinical evaluation;2.Aged between 30 and 80 years;3.Able to walk independently and complete gait testing;4.Normal cognitive function capable of cooperating with the trial and approved by the institutional ethics committee with signed informed consent.

Exclusion criteria

Exclusion criteria: Parkinson's Disease Group:1.Presence of other serious systemic diseases (e.g., stroke, malignancy, or renal failure);2.Severe cognitive impairment as defined by MMSE thresholds: illiterate <14, primary education <20, above primary education <24;3.Inability to receive acupuncture at acupoints due to dermatologic conditions, limb defects, or other factors;4.Inability to cooperate due to blindness or deafness;5.Presence of other conditions that may affect gait;6.Participation in other clinical trials or receipt of acupuncture within the past 30 days;7.History of drug or alcohol abuse;8.Pregnancy or breastfeeding. Healthy Control Group:1.Presence of other serious systemic diseases (e.g., stroke, malignancy, or renal failure);2.Severe cognitive impairment as defined by MMSE thresholds: illiterate <14, primary education <20, above primary education <24;3.Inability to receive acupuncture at acupoints due to dermatologic conditions, limb defects, or other factors;4.Inability to cooperate due to blindness or deafness;5.Presence of other conditions that may affect gait;6.Participation in other clinical trials or receipt of acupuncture within the past 30 days;7.History of drug or alcohol abuse;8.Pregnancy or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Unified Parkinsons Disease Rating Scale Part III;

Secondary

MeasureTime frame
Treatment Compliance;Adverse Event Assessment;Levodopa Equivalent Daily Dose (LEDD);Modified Hoehn and Yahr staging;Surface Electromyography;Parkinsons Disease Quality of Life Questionnaire;Inbody body composition parameters;Gait feature parameters;Balance Ability Scale;

Countries

China

Contacts

Public ContactXiaoqing Jin

Zhejiang Hospital

zjyyjxq@163.com+86 133 5710 2177

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026